These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24450538)

  • 21. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work.
    Liira J; Verbeek JH; Costa G; Driscoll TR; Sallinen M; Isotalo LK; Ruotsalainen JH
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009776. PubMed ID: 25113164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss.
    Dinges DF; Arora S; Darwish M; Niebler GE
    Curr Med Res Opin; 2006 Jan; 22(1):159-67. PubMed ID: 16393442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Armodafinil in the treatment of excessive sleepiness.
    Bogan RK
    Expert Opin Pharmacother; 2010 Apr; 11(6):993-1002. PubMed ID: 20307223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
    Roth T; Rippon GA; Arora S
    Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy, Safety, and Tolerability of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies: A Pilot Study.
    Lapid MI; Kuntz KM; Mason SS; Aakre JA; Lundt ES; Kremers W; Allen LA; Drubach DA; Boeve BF
    Dement Geriatr Cogn Disord; 2017; 43(5-6):269-280. PubMed ID: 28448998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S; Khalid M; Tulaimat A
    J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Armodafinil.
    Garnock-Jones KP; Dhillon S; Scott LJ
    CNS Drugs; 2009 Sep; 23(9):793-803. PubMed ID: 19689169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian phase, sleepiness, and light exposure assessment in night workers with and without shift work disorder.
    Gumenyuk V; Roth T; Drake CL
    Chronobiol Int; 2012 Aug; 29(7):928-36. PubMed ID: 22823876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study.
    Greve DN; Duntley SP; Larson-Prior L; Krystal AD; Diaz MT; Drummond SP; Thein SG; Kushida CA; Yang R; Thomas RJ
    J Clin Sleep Med; 2014 Feb; 10(2):143-53. PubMed ID: 24532997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing the patient with shift-work disorder.
    Thorpy MJ
    J Fam Pract; 2010 Jan; 59(1 Suppl):S24-31. PubMed ID: 20074507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Armodafinil for fatigue associated with menopause: an open-label trial.
    Meyer F; Freeman MP; Petrillo L; Barsky M; Galvan T; Kim S; Cohen L; Joffe H
    Menopause; 2016 Feb; 23(2):209-14. PubMed ID: 26125538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Armodafinil for excessive daytime sleepiness.
    Nishino S; Okuro M
    Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome.
    Kingshott RN; Vennelle M; Coleman EL; Engleman HM; Mackay TW; Douglas NJ
    Am J Respir Crit Care Med; 2001 Mar; 163(4):918-23. PubMed ID: 11282766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
    Ronnebaum S; Bron M; Patel D; Menno D; Bujanover S; Kratochvil D; Lucas E; Stepnowsky C
    J Clin Sleep Med; 2021 Dec; 17(12):2543-2555. PubMed ID: 34402784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study.
    Ketter TA; Amchin J; Frye MA; Gross N
    J Affect Disord; 2016 Jun; 197():51-7. PubMed ID: 26970266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long working hours and the night shift on severe sleepiness among workers with 12-hour shift systems for 5 to 7 consecutive days in the automobile factories of Korea.
    Son M; Kong JO; Koh SB; Kim J; Härmä M
    J Sleep Res; 2008 Dec; 17(4):385-94. PubMed ID: 19021859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleepiness and driving events in shift workers: the impact of circadian and homeostatic factors.
    Mulhall MD; Sletten TL; Magee M; Stone JE; Ganesan S; Collins A; Anderson C; Lockley SW; Howard ME; Rajaratnam SMW
    Sleep; 2019 Jun; 42(6):. PubMed ID: 30882154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.